摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione

中文名称
——
中文别名
——
英文名称
7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione
英文别名
7-[2-(3,5-dibromo-4-hydroxyphenyl)ethylamino]quinoline-5,8-dione
7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione化学式
CAS
——
化学式
C17H12Br2N2O3
mdl
——
分子量
452.1
InChiKey
OHPHDPYJEHZGDE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.9
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    79.3
  • 氢给体数:
    2
  • 氢受体数:
    5

文献信息

  • RESIN COMPOSITION FOR FOAM, FOAM, AND WALLPAPER
    申请人:Toppan Printing Co., Ltd.
    公开号:EP2832783A1
    公开(公告)日:2015-02-04
    A resin foam composition comprises, at least, a resin emulsion and cellulose nanofibers.
    树脂泡沫组合物至少包括树脂乳液和纤维素纳米纤维。
  • Resin foam composition and foam, and wallpaper
    申请人:Toppan Printing Co., Ltd.
    公开号:US11161953B2
    公开(公告)日:2021-11-02
    A resin foam composition comprises, at least, a resin emulsion and cellulose nanofibers.
    树脂泡沫组合物至少包括树脂乳液和纤维素纳米纤维。
  • T5 exonuclease-based method to identify DNA topoisomerase inhibitors
    申请人:Leng Fenfei
    公开号:US11268129B1
    公开(公告)日:2022-03-08
    The present invention provides assays and methods for studying DNA topology and topoisomerases. The assays and methods utilize a circular plasmid DNA comprising one or more hairpin structures and the ability of T5 exonuclease (T5E) to digest the circular plasmid DNA in a specific configuration. The assays and methods can be used as a high throughput screening for inhibitors of, for example, DNA gyrases and DNA topoisomerases I for anticancer drug and antibiotics discovery.
    本发明提供了研究DNA拓扑结构和拓扑异构酶的检测方法。这些检测方法利用包含一个或多个发夹结构的环状质粒 DNA 以及 T5 外切酶(T5E)以特定构型消化环状质粒 DNA 的能力。这些检测方法可用于高通量筛选 DNA 回旋酶和 DNA 拓扑异构酶 I 等的抑制剂,以发现抗癌药物和抗生素。
  • Protein tyrosine phosphatase-prl-1 a a marker and therapeutic target for pancreatic cancer
    申请人:Farnsworth L Amanda
    公开号:US20070026398A1
    公开(公告)日:2007-02-01
    Using gene expression profiling, the present Invention identifies Protein tyrosine phosphatase IVA member 1 (PRL-1) as a diagnostic marker and therapeutic target for pancreatic cancer. The Invention therefore provides methods for prediction and detection of PRL-1 associated cancers, and evaluation of inhibitors of PRL-1. The Invention also provides a method of treating or preventing pancreatic cancer in a subject.
  • METHODS AND COMPOUNDS FOR REGULATING APOPTOSIS
    申请人:Reed John C.
    公开号:US20090118135A1
    公开(公告)日:2009-05-07
    An assay for determining compounds that inhibit activity of a BCl-2 protein, or affect conversion of Bcl-2 from an antiapoptotic to a proapoptotic form are described. In addition, compounds that modulate the function of anti-apoptotic proteins such as Bcl-2 and related Bcl-2 family members are identified.
查看更多